Quebec SEAO #2026-3531

PrisMax CRRT devices and compatible hemofiltration supplies

Santé Québec is seeking dedicated PrisMax hemofiltration supplies and two additional CRRT devices for its Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval. - Buyer: Santé Québec, Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval. - Proposed supplier and OEM: Vantive ULC; the requested equipment brands are PrisMax and TherMax. - Equipment: 2 PrisMax continuous renal replacement therapy (CRRT) devices, each with an integrated TherMax blood warmer. Each must support SCUF, CVVH, CVVHD, and CVVHDF protocols. - Supplies: PrisMax-compatible effluent bags, calcium connection tubing, and an auto-effluent system; disposable TherMax warmer bags; AN69ST CRRT filter sets for patients over 30 kg; and four types of sterile CRRT solutions. Quantities and part numbers for supplies are not specified. - Solution formulations: One solution contains lactic acid, magnesium chloride hexahydrate, sodium bicarbonate, and sodium chloride; another contains sodium chloride and sodium citrate; a third contains calcium chloride dihydrate, lactic acid, magnesium chloride hexahydrate, sodium bicarbonate, and sodium chloride; and a fourth adds anhydrous glucose and potassium chloride to the third formulation. - Notable requirements: Devices must provide temperature-controlled blood warming, automatic effluent drainage, touchscreen setup and operating guidance, intelligent alarms, in-treatment fluid-removal adjustment, pre-connected filter tubing, automatic degassing-chamber fluid-level adjustment, and integrated citrate anticoagulation. Products must have current establishment licensing and Health Canada authorization; alternative proposals must meet the stated requirements. - Term and delivery: Expected delivery is over a two-year window. The estimated contract term is 36 months, with options extending it to 60 months; a renewal option applies to PrisMax-dedicated consumables.

Description

The notice concerns the procurement of supplies compatible with the IUCPQ-UL’s PrisMax hemofiltration systems and the addition of two PrisMax devices, each equipped with an integrated TherMax blood warmer. Required supplies include dedicated disposable components and sterile solutions for continuous renal replacement therapy. The devices must support specified CRRT protocols and meet the technical, licensing, and Health Canada authorization requirements listed in the notice. The notice identifies Vantive ULC as the proposed supplier and states that the procurement precedes a negotiated contract.

View original listing